Infectious Diseases

502 questions

Question 1Question →

A 67-year-old man is evaluated on hospital day 3. He was initially admitted for fever, chills, and left flank pain. His past medical history is significant for a T10 spinal cord injury resulting in neurogenic bladder, managed with intermittent clean catheterization. On presentation to the emergency department, his temperature was 39.1∘C39.1^\circ\text{C} (102.4∘F102.4^\circ\text{F}), blood pressure was 92/58 mmHg92/58\text{ mmHg}, and heart rate was 114/min114/\text{min}. Laboratory testing demonstrated a leukocyte count of 16,500/mm316,500/\text{mm}^3. He was aggressively resuscitated with intravenous fluids and empirically started on intravenous piperacillin-tazobactam and vancomycin for presumed urosepsis.

Today, the patient's temperature is 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure is 122/78 mmHg122/78\text{ mmHg}, and heart rate is 82/min82/\text{min}. He has been afebrile for the last 36 hours and is tolerating a normal oral diet. His flank pain has resolved. The urine culture collected on admission has finalized, growing >105 CFU/mL>10^5\text{ CFU/mL} of *Enterococcus faecalis*. Susceptibility testing results are as follows:

AntimicrobialInterpretation
AmpicillinSusceptible
VancomycinSusceptible
LinezolidSusceptible
LevofloxacinResistant

Blood cultures drawn on admission show no growth after 48 hours. Which of the following is the most appropriate next step in the patient's antimicrobial management?

Show answer & explanation

Answer: Discontinue current antibiotics and start oral amoxicillin

Answer

The most appropriate step is to discontinue the current antibiotics and start oral amoxicillin.
The correct action is to transition the patient to oral amoxicillin. This scenario tests the core principles of antimicrobial stewardship: de-escalation of therapy and the transition from intravenous to oral medications. The patient originally presented with urosepsis and was appropriately started on broad-spectrum empiric therapy. However, he is now hemodynamically stable, afebrile, and tolerating oral intake, making him an ideal candidate for oral step-down therapy. The culture confirms *Enterococcus faecalis* that is susceptible to ampicillin. Amoxicillin (the oral equivalent of ampicillin) is the drug of choice for ampicillin-susceptible enterococcal urinary tract infections due to its targeted narrow spectrum, high oral bioavailability, and excellent concentration in the urine.

Step-by-Step Solution

1
Assess the patient's current clinical status and need for intravenous therapy.
The patient is hemodynamically stable, afebrile for 36 hours, and tolerating an oral diet.
Clinical stability and intact gastrointestinal absorption indicate that the patient is eligible for transition from intravenous to oral antimicrobial therapy.
2
Analyze the culture and susceptibility data.
The causative pathogen is Enterococcus faecalis, which is susceptible to ampicillin, vancomycin, and linezolid.
Empiric broad-spectrum therapy must be de-escalated to the narrowest effective agent once the pathogen is identified to prevent antimicrobial resistance.
3
Select the optimal targeted, narrow-spectrum agent.
Oral amoxicillin is selected.
Amoxicillin provides targeted coverage for ampicillin-susceptible E. faecalis, has excellent oral bioavailability, and reaches high concentrations in the urinary tract.

Key Concept

In patients with clinical improvement and culture data, empiric broad-spectrum antibiotics should be de-escalated to targeted, narrow-spectrum oral agents to optimize therapy and adhere to antimicrobial stewardship principles.
Question 2Question →

A male patient, aged 5858, presents to the emergency department complaining of a 33-day history of fever, chills, and severe left knee swelling. He has a past medical history significant for type 22 diabetes mellitus but denies any recent falls or joint trauma. Initial vital signs reveal a temperature of 39.1∘C39.1^\circ\text{C} (102.4∘F102.4^\circ\text{F}), blood pressure of 110/70 mm Hg110/70\text{ mm Hg}, and heart rate of 112/min112/\text{min}. Physical examination highlights a warm, intensely erythematous, and exquisitely tender left knee with a noticeable effusion.

Arthrocentesis is performed, yielding frankly purulent synovial fluid with a leukocyte count of 85,000/mm385,000/\text{mm}^3 (90%90\% neutrophils). Blood and synovial fluid cultures are obtained, and he is empirically started on intravenous vancomycin and ceftriaxone before undergoing urgent arthroscopic lavage.

On hospital day 33, the patient demonstrates clinical improvement and is currently afebrile. The microbiology laboratory reports that both the synovial fluid and blood cultures are growing *Staphylococcus aureus*. Susceptibility testing demonstrates that the isolate is resistant to penicillin but susceptible to oxacillin, cefazolin, and clindamycin. The patient's allergy profile notes a mild, non-pruritic maculopapular rash that occurred after taking amoxicillin during childhood; he has never experienced anaphylaxis, angioedema, or respiratory compromise associated with any medication.

Which of the following is the most appropriate antimicrobial regimen for this patient going forward?

Show answer & explanation

Answer: Intravenous cefazolin

Answer

Intravenous cefazolin
The correct choice is intravenous cefazolin. The patient presents with septic arthritis and concurrent bacteremia caused by methicillin-susceptible *Staphylococcus aureus* (MSSA), as indicated by the isolate's susceptibility to oxacillin. For invasive MSSA infections, antistaphylococcal beta-lactams (such as cefazolin, nafcillin, or oxacillin) are the definitive drugs of choice. These agents are associated with significantly lower mortality and lower rates of clinical failure compared to vancomycin. Furthermore, the patient's history of a mild, non-pruritic maculopapular rash to amoxicillin is not a contraindication to cefazolin. First-generation cephalosporins have distinct side chains, and cross-reactivity in non-anaphylactic penicillin allergies is exceptionally low.

Step-by-Step Solution

1
Interpret the microbiology and susceptibility data.
The pathogen is methicillin-susceptible Staphylococcus aureus (MSSA).
Susceptibility to oxacillin indicates that the Staphylococcus aureus isolate does not possess the mecA gene, defining it as MSSA rather than MRSA.
2
Evaluate the patient's reported medication allergy.
The patient's childhood maculopapular rash to amoxicillin is a mild, non-IgE mediated reaction.
First-generation cephalosporins like cefazolin have distinct R1 side chains compared to amoxicillin, resulting in extremely low cross-reactivity (<1%). They are safe to administer unless there is a history of severe IgE-mediated reactions (e.g., anaphylaxis) or severe delayed reactions (e.g., Stevens-Johnson syndrome).
3
Determine the optimal definitive antimicrobial agent and route.
Intravenous cefazolin should be initiated.
For severe MSSA infections such as bacteremia and septic arthritis, antistaphylococcal beta-lactams (cefazolin, nafcillin, oxacillin) are superior to vancomycin. The intravenous route must be maintained for several weeks to ensure eradication.

Key Concept

Definitive management of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia and interpretation of beta-lactam cross-reactivity.
Estimated Time:1m 30s
Question 3Question →

A 3131-year-old male landscape architect seeks medical evaluation at a walk-in clinic in Rhode Island during mid-July. He describes a five-day history of low-grade fevers, profound fatigue, and a spreading skin lesion on his back. Yesterday, he began experiencing difficulty holding liquids in his mouth and noticed an inability to completely shut his right eye. Vital signs are temperature 37.8∘C37.8^\circ\text{C} (100.0∘F100.0^\circ\text{F}), blood pressure 122/78 mmHg122/78\text{ mmHg}, pulse 74/min74/\text{min}, and respiratory rate 14/min14/\text{min}. Physical examination reveals a 12 cm12\text{ cm} annular, erythematous plaque with a distinct zone of central clearing on the right subscapular region. Neurologic examination demonstrates drooping of the right corner of the mouth, flattening of the right nasolabial fold, and an inability to close the right eyelid. Sensation to light touch on the face is intact. There is no nuchal rigidity, and the remainder of the examination is unremarkable. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Prescribe a course of oral doxycycline

Answer

Prescribe a course of oral doxycycline to treat early disseminated Lyme disease presenting with erythema migrans and an isolated facial nerve palsy.
This patient presents with a classic erythema migrans rash and a unilateral lower motor neuron facial nerve palsy, which are hallmark findings of early disseminated Lyme disease caused by the spirochete Borrelia burgdorferi. The diagnosis of Lyme disease in the presence of an erythema migrans rash is strictly clinical. For patients with Lyme disease who have an isolated facial nerve palsy (without clinical evidence of meningitis, such as nuchal rigidity, severe headache, or photophobia), oral doxycycline is the preferred treatment. Intravenous therapy is not indicated for isolated cranial neuropathies and represents poor antibiotic stewardship.

Step-by-Step Solution

1
Identify the primary clinical syndrome from the dermatologic and neurologic findings.
The patient has a pathognomonic erythema migrans (target-like) rash and an isolated lower motor neuron facial nerve palsy.
Recognizing erythema migrans in an endemic area establishes a definitive clinical diagnosis of Lyme disease without the need for serologic confirmation.
2
Determine the stage of the disease.
The presence of multiple systemic signs (rash plus cranial neuropathy) classifies this as early disseminated Lyme disease.
Staging guides the appropriate route, spectrum, and duration of antimicrobial therapy.
3
Select the appropriate targeted antimicrobial therapy.
Oral doxycycline is chosen because the patient has an isolated facial nerve palsy without signs of meningitis or severe carditis.
Oral therapy is highly effective for isolated cranial nerve involvement in Lyme disease, adhering to principles of good antibiotic stewardship by avoiding unnecessary intravenous broad-spectrum agents.

Key Concept

Early disseminated Lyme disease presenting with isolated facial nerve palsy should be treated with targeted oral antibiotics (e.g., doxycycline); intravenous ceftriaxone is reserved for more severe neurologic involvement such as meningitis.
Question 4Question →

A 64-year-old man is evaluated in the intensive care unit for a persistent fever. He was admitted 8 days ago after a severe motor vehicle collision that resulted in multiple rib fractures, a pulmonary contusion, and a splenectomy. He has been mechanically ventilated since admission. Three days ago, he developed a temperature of 38.9°C (102.0°F), increased purulent endotracheal secretions, and increased oxygen requirements. A chest radiograph revealed a new right lower lobe consolidation. He was empirically started on intravenous cefepime, vancomycin, and amikacin. Today, his temperature is 37.4°C (99.3°F), and his oxygen requirements have decreased. The endotracheal aspirate culture from three days ago has grown Pseudomonas aeruginosa (>100,000 CFU/mL). Susceptibility testing shows the isolate is susceptible to cefepime, meropenem, piperacillin-tazobactam, and amikacin, but resistant to ciprofloxacin. No other organisms, including Staphylococcus aureus, have grown. Blood cultures obtained prior to antibiotic initiation are negative. Which of the following is the most appropriate next step in this patient's pharmacotherapy?

Show answer & explanation

Answer: Discontinue vancomycin and amikacin, and continue cefepime

Answer

The most appropriate next step is to discontinue vancomycin and amikacin, and continue therapy with cefepime alone.
The correct answer is to discontinue vancomycin and amikacin, and continue cefepime alone. This patient initially presented with ventilator-associated pneumonia (VAP) and appropriately received broad-spectrum empiric therapy targeting MRSA (vancomycin) and resistant Gram-negative organisms, including Pseudomonas (cefepime and amikacin). At 48 to 72 hours, when culture data return, therapy must be de-escalated. Because no MRSA was isolated, vancomycin can be safely discontinued. Furthermore, although empiric double antipseudomonal coverage is standard for critically ill patients at risk for multidrug-resistant organisms, definitive therapy should utilize a single active beta-lactam agent once susceptibilities are confirmed. Continuing an aminoglycoside like amikacin offers no survival benefit for definitive therapy and exposes the patient to nephrotoxicity and ototoxicity.

Step-by-Step Solution

1
Identify the patient's clinical diagnosis and indication for antibiotics.
The patient has ventilator-associated pneumonia (VAP) as evidenced by fever, purulent secretions, new lung consolidation, and positive respiratory cultures after >48 hours of mechanical ventilation.
Establishing the diagnosis determines the appropriate treatment guidelines to apply.
2
Analyze the culture and susceptibility results relative to the empiric antibiotic regimen.
Cultures grew only Pseudomonas aeruginosa susceptible to cefepime. Methicillin-resistant Staphylococcus aureus (MRSA) was not isolated.
Empiric therapy must be adjusted based on definitive microbiological data to prevent antibiotic resistance and drug toxicity.
3
Apply principles of antibiotic stewardship to de-escalate the regimen.
Vancomycin should be stopped because MRSA is absent. Amikacin should be stopped because combination therapy for Pseudomonas is only required empirically; definitive therapy requires only a single active beta-lactam agent (cefepime).
Guidelines recommend transitioning from broad-spectrum empiric therapy to targeted monotherapy once susceptibilities are known.

Key Concept

In the management of ventilator-associated pneumonia, empiric broad-spectrum therapy (e.g., MRSA coverage and double antipseudomonal coverage) should be promptly de-escalated to a single targeted agent once culture and susceptibility results are available and the patient is clinically improving.
Estimated Time:1m 30s
Question 5Question →

Match each clinical presentation of a newly diagnosed HIV patient with the most appropriate timing and rationale for initiating antiretroviral therapy (ART).

Click a left item, then click its matching right item

Items

A 3535-year-old patient with newly diagnosed HIV (CD4 count 3030 cells/mm3\text{mm}^3) presents with progressive headache, fever, and lethargy. Cerebrospinal fluid analysis reveals a significantly elevated opening pressure and a positive polysaccharide antigen test.
A 4242-year-old patient with newly diagnosed HIV (CD4 count 4545 cells/mm3\text{mm}^3) presents with chronic cough, night sweats, and weight loss. Sputum smear is positive for acid-fast bacilli.
A 2929-year-old patient with newly diagnosed HIV (CD4 count 160160 cells/mm3\text{mm}^3) presents with a cavitary apical lung lesion. Sputum nucleic acid amplification testing is positive for Mycobacterium tuberculosis.
A 5050-year-old patient with newly diagnosed HIV (CD4 count 3535 cells/mm3\text{mm}^3) presents with unilateral blurred vision and floaters. Fundoscopic examination reveals perivascular yellow-white retinal exudates and prominent retinal hemorrhages.

Matches

Show answer & explanation

Answer

The patient with cryptococcal meningitis matches with deferring ART 22 to 1010 weeks to prevent fatal CNS IRIS. The patient with tuberculosis and a CD4 count <50< 50 matches with initiating ART within 22 weeks to maximize survival. The patient with tuberculosis and a CD4 count >50> 50 matches with initiating ART between 22 and 88 weeks. The patient with CMV retinitis matches with deferring ART 11 to 22 weeks to prevent vision-threatening immune recovery uveitis.
The timing of ART initiation in the setting of acute opportunistic infections requires a delicate balance between rapidly restoring immune function to improve survival and avoiding Immune Reconstitution Inflammatory Syndrome (IRIS). For cryptococcal meningitis, the risk of fatal CNS IRIS is unacceptably high, necessitating a 22 to 1010 week delay. For tuberculosis, the survival benefit of very early ART (within 22 weeks) outweighs the risk of TB-IRIS only in profoundly immunosuppressed patients (CD4 <50< 50). For TB patients with CD4 counts >50> 50, ART should be delayed 22 to 88 weeks. For CMV retinitis, a 11 to 22 week delay is required to prevent immune recovery uveitis and subsequent blindness.

Step-by-Step Solution

1
Identify the underlying opportunistic infection (OI) for each patient based on the clinical presentation and diagnostic findings.
Patient 1 has cryptococcal meningitis, Patient 2 has active pulmonary tuberculosis, Patient 3 has active pulmonary tuberculosis, and Patient 4 has CMV retinitis.
Recognizing the specific OI is the critical first step because antiretroviral therapy (ART) initiation guidelines are inherently disease-specific.
2
Determine the patient's CD4 count for those with tuberculosis.
Patient 2 has a CD4 count <50< 50 cells/mm3\text{mm}^3, whereas Patient 3 has a CD4 count >50> 50 cells/mm3\text{mm}^3.
For active tuberculosis, the optimal timing of ART depends heavily on the degree of immunosuppression to balance the survival benefit against the risk of Immune Reconstitution Inflammatory Syndrome (IRIS).
3
Apply the guideline-based timing for ART initiation for each specific OI and CD4 category.
Cryptococcal meningitis requires a 22-1010 week delay; TB with CD4 <50< 50 requires ART within 22 weeks; TB with CD4 >50> 50 requires ART in 22-88 weeks; CMV retinitis requires a 11-22 week delay.
Following these specific guidelines minimizes the risk of fatal or organ-threatening IRIS while maximizing overall patient survival.

Key Concept

Timing of Antiretroviral Therapy (ART) Initiation in HIV-Associated Opportunistic Infections
Question 6Question →

A 38-year-old woman is hospitalized for a 1-week history of severe lower back pain, generalized weakness, and recurrent chills. Her medical history is significant for intravenous drug use. Her temperature is 39.2∘C39.2^\circ C (102.6∘F102.6^\circ F), blood pressure is 112/68 mm Hg112/68 \text{ mm Hg}, and pulse is 115/min115/\text{min}. Physical examination reveals a new III/VI holosystolic murmur loudest at the cardiac apex. There is pronounced point tenderness over the lower lumbar spine, but no focal neurologic deficits are present. Laboratory studies show a leukocyte count of 15,200/μL15,200/\mu L. Magnetic resonance imaging of the spine demonstrates abnormal signal intensity in the L4-L5 intervertebral disc and adjacent vertebral bodies, consistent with discitis and osteomyelitis. Blood cultures are drawn, and empiric therapy with intravenous vancomycin and cefepime is initiated. On hospital day 3, the patient's fever has improved. A transesophageal echocardiogram reveals a 1.4-cm vegetation on the mitral valve. Blood cultures are finalized and grow *Staphylococcus aureus* that is resistant to penicillin but susceptible to oxacillin, cefazolin, daptomycin, and vancomycin. Which of the following is the most appropriate next step in pharmacotherapy?

Show answer & explanation

Answer: Discontinue the current regimen and initiate intravenous cefazolin

Answer

Discontinue the current regimen and initiate intravenous cefazolin
For severe, deep-seated infections caused by methicillin-susceptible *Staphylococcus aureus* (MSSA), such as left-sided infective endocarditis and vertebral osteomyelitis, targeted beta-lactam antibiotics (e.g., cefazolin, nafcillin, or oxacillin) are the definitive treatment of choice. Clinical data consistently demonstrate that these beta-lactams are superior to vancomycin for MSSA, leading to more rapid clearance of bacteremia and lower rates of treatment failure and mortality. Therefore, the principles of antimicrobial stewardship and optimal clinical care dictate prompt de-escalation from empiric broad-spectrum coverage to a narrow-spectrum beta-lactam once susceptibilities confirm MSSA.

Step-by-Step Solution

1
Interpret the blood culture susceptibilities.
The organism is Staphylococcus aureus susceptible to oxacillin.
Oxacillin susceptibility defines the isolate as methicillin-susceptible Staphylococcus aureus (MSSA).
2
Determine the optimal antibiotic class for MSSA bacteremia, endocarditis, and osteomyelitis.
Narrow-spectrum, anti-staphylococcal beta-lactams are the treatment of choice.
Clinical evidence consistently shows that anti-staphylococcal penicillins (nafcillin, oxacillin) or first-generation cephalosporins (cefazolin) have superior efficacy, lower mortality rates, and lower relapse rates compared to vancomycin for MSSA infections.
3
Select the appropriate management step based on principles of antibiotic stewardship.
De-escalate the empiric broad-spectrum regimen to intravenous cefazolin.
De-escalation improves patient outcomes by utilizing the most effective targeted therapy while minimizing unnecessary broad-spectrum exposure (reducing toxicity and resistance).

Key Concept

Targeted antimicrobial therapy (de-escalation) for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia and endocarditis.
Question 7Question →

A 58-year-old woman is hospitalized for the treatment of infective endocarditis. She initially presented with a 3-week history of low-grade fever, fatigue, and a new heart murmur. Her history is notable for a dental extraction one month prior. Transesophageal echocardiography on admission revealed a 7-mm vegetation on the mitral valve leaflet. Three sets of blood cultures grew *Streptococcus sanguinis* with a penicillin minimum inhibitory concentration (MIC) of 0.05 mcg/mL. She was started on a planned 2-week synergistic regimen of intravenous aqueous penicillin G and intravenous gentamicin. On day 5 of hospitalization, the patient reports feeling clinically improved and has been afebrile for 48 hours. However, laboratory studies show her serum creatinine has increased from a baseline of 0.8 mg/dL to 2.1 mg/dL. Her urine output has mildly decreased over the past 24 hours. Which of the following is the most appropriate modification to her antimicrobial regimen?

Show answer & explanation

Answer: Discontinue gentamicin and continue intravenous penicillin G for a total 4-week course

Answer

Discontinue gentamicin and continue intravenous penicillin G for a total 4-week course
The correct answer identifies that the patient has developed aminoglycoside-induced acute kidney injury. Standard treatment guidelines for native valve endocarditis caused by highly penicillin-susceptible viridans group streptococci (MIC ≤ 0.12 mcg/mL) offer two primary first-line regimens: 4 weeks of IV penicillin (or ceftriaxone) monotherapy, OR a 2-week synergistic course of IV penicillin (or ceftriaxone) combined with gentamicin. If a patient experiences significant nephrotoxicity or ototoxicity while on the 2-week synergistic regimen, the aminoglycoside must be discontinued immediately. To ensure complete eradication of the infection, the patient is then transitioned to the 4-week monotherapy protocol, counting the days already completed.

Step-by-Step Solution

1
Identify the primary complication occurring in the patient.
The patient has developed acute kidney injury (AKI), evidenced by a rise in serum creatinine from 0.8 mg/dL to 2.1 mg/dL and decreased urine output.
Recognizing the complication is essential to determining which medication is causing harm.
2
Determine the likely cause of the complication.
Gentamicin is a well-known nephrotoxic aminoglycoside and is the most likely culprit for the patient's intrinsic acute tubular necrosis.
Identifying the offending agent dictates the required therapeutic modification.
3
Select the appropriate alternative evidence-based regimen for the infection.
For native valve endocarditis caused by highly penicillin-susceptible viridans group streptococci (MIC ≤ 0.12 mcg/mL), a 4-week course of intravenous penicillin G monotherapy is equivalent in efficacy to the 2-week synergistic regimen.
Stopping the toxic agent and relying on the safe, targeted monotherapy protocol prevents further renal damage while ensuring the endocarditis is fully treated.

Key Concept

In patients receiving a 2-week synergistic course of penicillin and gentamicin for highly penicillin-susceptible viridans group streptococcal endocarditis who develop acute kidney injury, the aminoglycoside should be discontinued, and penicillin monotherapy should be extended to a full 4-week course.
Question 8Question →

A 6565-year-old man with a history of a renal transplantation presents to the emergency department with a 11-day history of fever, severe headache, and confusion. His temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure is 110/70 mm Hg110/70\text{ mm Hg}, and pulse is 115/min115/\text{min}. Physical examination reveals nuchal rigidity and bilateral papilledema. He is suspected of having acute bacterial meningitis. Arrange the following diagnostic and therapeutic steps in the most appropriate sequential order for managing this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Obtain blood cultures, Administer empiric intravenous antibiotics and dexamethasone, Perform a non-contrast CT scan of the head, and Perform a lumbar puncture.
In the management of suspected bacterial meningitis, blood cultures must be drawn first to help identify the causative organism. Because this patient has 'red flags' (papilledema, altered mental status, and an immunocompromised state) that require a CT scan before a lumbar puncture to prevent cerebral herniation, empiric antibiotics must not be delayed while waiting for neuroimaging. Therefore, antibiotics are administered immediately after blood cultures are drawn, followed by the CT scan, and finally the lumbar puncture.

Step-by-Step Solution

1
Recognize the clinical presentation of suspected acute bacterial meningitis with high-risk features.
The patient has signs of meningitis (fever, headache, nuchal rigidity) along with red flags for increased intracranial pressure (papilledema, confusion) and an immunocompromised state (renal transplant).
Identifying these features determines the appropriate sequence of diagnostic and therapeutic interventions.
2
Determine the very first step in management.
Blood cultures should be obtained immediately.
Drawing blood cultures before administering antibiotics is crucial for isolating the pathogen without delaying treatment.
3
Determine the timing of empiric therapy.
Administer empiric intravenous antibiotics and dexamethasone immediately after drawing blood cultures.
Because a CT scan is required before a lumbar puncture, definitive CSF analysis will be delayed. Antibiotics must not be withheld during this delay, as mortality increases significantly.
4
Assess the need and timing for neuroimaging.
Perform a non-contrast CT scan of the head next.
Due to the patient's papilledema, confusion, and immunocompromised status, a CT scan is necessary to rule out mass effect before safely performing a lumbar puncture.
5
Determine the final step once neuroimaging is cleared.
Perform a lumbar puncture.
Once the CT scan confirms the absence of a mass lesion or midline shift, it is safe to proceed with the lumbar puncture to obtain CSF for analysis and culture.

Key Concept

In patients with suspected bacterial meningitis who have indications for a CT scan before lumbar puncture (e.g., papilledema, immunocompromised state, focal neurologic deficit, altered mental status), blood cultures must be drawn first, followed immediately by empiric antibiotics. The CT scan is then performed, followed by the lumbar puncture if considered safe.
Question 9Question →

An 8282-year-old man is evaluated in the preadmission clinic prior to a scheduled elective right total knee arthroplasty. His past medical history is significant for hypertension, type 22 diabetes mellitus, and benign prostatic hyperplasia. He reports feeling well and specifically denies dysuria, urinary frequency, urgency, gross hematuria, or flank pain. Vital signs are temperature 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure 130/80 mmHg130/80\text{ mmHg}, pulse 72/min72\text{/min}, and respirations 14/min14\text{/min}. Physical examination is unremarkable, with no costovertebral angle tenderness or suprapubic pain. A routine preoperative urinalysis reveals trace leukocyte esterase, positive nitrites, and 1515-2020 white blood cells per high-power field. Which of the following is the most appropriate next step in management regarding this patient's urinary findings?

Show answer & explanation

Answer: Proceed with the scheduled surgery without targeted antimicrobial therapy for the urinary findings

Answer

Proceed with the scheduled surgery without targeted antimicrobial therapy for the urinary findings
The correct action is to proceed with the surgery without targeted therapy. This patient has asymptomatic bacteriuria (ASB), which is common in older men with benign prostatic hyperplasia and patients with diabetes mellitus. By definition, ASB is the presence of bacteria in the urine without accompanying signs or symptoms of a urinary tract infection (e.g., dysuria, frequency, urgency, fever, suprapubic pain). According to current infectious disease guidelines and antimicrobial stewardship principles, screening and treatment for ASB are strongly discouraged for the vast majority of patients. The only well-established indications for screening and treating ASB are in pregnant women, patients undergoing endoscopic urologic procedures associated with mucosal trauma (e.g., transurethral resection of the prostate), and in patients who have recently received a renal transplant. An elective orthopedic procedure, such as a total knee arthroplasty, is not an indication to treat ASB. Studies have consistently shown that treating ASB prior to joint arthroplasty does not reduce the risk of surgical site infections and only serves to promote antibiotic resistance and potential adverse drug effects.

Step-by-Step Solution

1
Identify the patient's clinical state based on symptoms and labs.
The patient is an elderly diabetic man with pyuria and positive nitrites on urinalysis, but he entirely lacks systemic or local genitourinary symptoms.
Differentiating between a symptomatic urinary tract infection (UTI) and asymptomatic bacteriuria (ASB) relies primarily on the presence or absence of clinical symptoms.
2
Diagnose the urinary condition.
The clinical picture is diagnostic of asymptomatic bacteriuria (ASB).
ASB is defined as the isolation of a specified quantitative count of bacteria in an appropriately collected urine specimen from an individual without signs or symptoms of a UTI.
3
Recall the indications for treating asymptomatic bacteriuria.
Treatment is only indicated for pregnant women, patients undergoing invasive endoscopic urologic procedures associated with mucosal trauma, and recent renal transplant recipients.
Routine treatment in other populations does not improve outcomes and increases the risk of resistance.
4
Determine the appropriate management for this specific preoperative patient.
A total knee arthroplasty is a non-urologic orthopedic procedure, meaning the ASB does not require treatment or a delay of the surgery.
Treating ASB prior to joint replacement surgery does not reduce the incidence of prosthetic joint infections.

Key Concept

Management of asymptomatic bacteriuria in the preoperative setting
Question 10Question →

A 62-year-old man is admitted to the hospital with a 3-week history of low-grade fevers, fatigue, and progressive shortness of breath. His medical history is significant for mitral valve prolapse with severe regurgitation. Temperature is 38.4∘C38.4^{\circ}\text{C} (101.1∘F101.1^{\circ}\text{F}), pulse is 102/min102/\text{min}, and blood pressure is 110/65 mmHg110/65 \text{ mmHg}. Cardiac examination reveals a grade 3/6 holosystolic murmur at the apex. Small, painless, erythematous macules are noted on the palms.

Laboratory studies show:
- Leukocyte count: 14,200/mm314,200/\text{mm}^3
- Hemoglobin: 10.4 g/dL10.4 \text{ g/dL}
- Serum creatinine: 2.6 mg/dL2.6 \text{ mg/dL} (baseline 0.9 mg/dL0.9 \text{ mg/dL} three months ago)

Urinalysis reveals 2+ protein, 15-20 red blood cells/hpf, and the presence of red blood cell casts.

Three sets of blood cultures are drawn, and empiric intravenous vancomycin and cefepime are initiated. Transesophageal echocardiography reveals a 1.4-cm1.4\text{-cm} oscillating vegetation on the posterior mitral leaflet.

On hospital day 3, all blood culture bottles grow *Enterococcus faecalis*. Antimicrobial susceptibility testing reveals the following minimum inhibitory concentrations (MIC):
- Ampicillin: ≤1 μg/mL\leq 1 \ \mu\text{g/mL} (Susceptible)
- Vancomycin: 1 μg/mL1 \ \mu\text{g/mL} (Susceptible)
- Gentamicin (high-level testing): Susceptible

The laboratory report includes a standard comment: 'Enterococci are intrinsically resistant to cephalosporins, antistaphylococcal penicillins, and clindamycin in vitro.'

The patient's serum creatinine remains elevated at 2.7 mg/dL2.7 \text{ mg/dL}.

Which of the following is the most appropriate definitive pharmacotherapy for this patient?

Show answer & explanation

Answer: Intravenous ampicillin and ceftriaxone

Answer

Intravenous ampicillin and ceftriaxone
The most appropriate definitive pharmacotherapy is intravenous ampicillin and ceftriaxone. Enterococcus faecalis infective endocarditis requires a bactericidal antimicrobial regimen, as monotherapy with ampicillin is only bacteriostatic against enterococci. Historically, bactericidal synergy was achieved by combining ampicillin with an aminoglycoside (e.g., gentamicin). However, this patient has developed severe acute kidney injury (creatinine 2.7 mg/dL) secondary to immune complex glomerulonephritis, rendering aminoglycosides highly contraindicated due to their significant nephrotoxicity. The combination of ampicillin and ceftriaxone has emerged as a first-line, nephron-sparing alternative. Although enterococci are intrinsically resistant to cephalosporins in vitro (as noted on the lab report), the combination is highly synergistic in vivo. Ampicillin saturates Penicillin-Binding Proteins 4 and 5 (PBP4/PBP5), while ceftriaxone saturates PBP2 and PBP3. This dual PBP saturation leads to highly effective bactericidal cell wall breakdown.

Step-by-Step Solution

1
Analyze the clinical and echocardiographic findings.
The patient has native valve infective endocarditis based on fever, new murmur, Janeway lesions, and a large vegetation on the mitral valve.
Establishes the diagnosis and the requirement for a prolonged bactericidal antimicrobial regimen.
2
Evaluate laboratory results, specifically renal function and urinalysis.
Identification of acute kidney injury (creatinine elevated to 2.7 mg/dL) with RBC casts, indicating immune complex glomerulonephritis.
Recognizing severe renal impairment is critical as it determines the contraindication of nephrotoxic agents like aminoglycosides.
3
Interpret microbiological culture and susceptibility data.
The pathogen is Enterococcus faecalis. It is susceptible to ampicillin, vancomycin, and high-level gentamicin.
Guides the transition from broad-spectrum empiric therapy to pathogen-directed definitive therapy.
4
Select the optimal bactericidal regimen that balances efficacy and safety.
Selection of ampicillin plus ceftriaxone.
This combination provides the necessary bactericidal synergy against E. faecalis while avoiding the nephrotoxicity of gentamicin, overcoming the noted in vitro cephalosporin resistance.

Key Concept

The treatment of Enterococcus faecalis infective endocarditis in patients with significant renal impairment requires synergistic dual beta-lactam therapy (ampicillin plus ceftriaxone) to achieve bactericidal activity while avoiding the nephrotoxicity associated with aminoglycosides.
Question 11Question →

A 68-year-old man is brought to the emergency department by his son because he has been acting confused since yesterday morning. For the past three days, he has also experienced subjective fevers, chills, and a cough productive of yellowish sputum. His medical history includes hypertension, benign prostatic hyperplasia, and osteoarthritis. He does not use tobacco, alcohol, or illicit substances. His temperature is 38.7∘C38.7^\circ\text{C} (101.7∘F101.7^\circ\text{F}), pulse is 102/min102/\text{min}, blood pressure is 115/70 mmHg115/70\text{ mmHg}, and respiratory rate is 24/min24/\text{min}. Pulse oximetry indicates an oxygen saturation of 92%92\% on room air. He appears acutely ill and is oriented only to person. Pulmonary auscultation reveals crackles and bronchial breath sounds over the left lower lung fields. Laboratory evaluation is notable for a leukocyte count of 15,500/mm315,500/\text{mm}^3 and a blood urea nitrogen (BUN) level of 24 mg/dL24\text{ mg/dL}. Chest radiography demonstrates a dense left lower lobe consolidation. The patient is admitted to the general medical ward. Which of the following is the most appropriate empiric pharmacotherapy for this patient?

Show answer & explanation

Answer: Intravenous ceftriaxone and azithromycin

Answer

Intravenous ceftriaxone and azithromycin
The correct answer is intravenous ceftriaxone and azithromycin. This patient presents with community-acquired pneumonia (CAP) and signs of significant severity, including confusion and an elevated blood urea nitrogen (BUN). Utilizing the CURB-65 scoring system, he scores 3 points (Confusion, BUN > 19 mg/dL, Age > 65), which mandates inpatient admission to a medical ward. Current guidelines recommend that non-ICU inpatients with CAP be treated empirically with a beta-lactam (such as intravenous ceftriaxone, cefotaxime, or ampicillin-sulbactam) combined with a macrolide (such as azithromycin). Alternatively, monotherapy with a respiratory fluoroquinolone (like levofloxacin or moxifloxacin) can be used. This beta-lactam plus macrolide combination effectively targets the most common typical organisms (e.g., Streptococcus pneumoniae, Haemophilus influenzae) as well as atypical organisms (e.g., Mycoplasma pneumoniae, Legionella pneumophila).

Step-by-Step Solution

1
Calculate the patient's severity using a validated scoring system such as CURB-65.
The patient scores 3 points (Confusion = 1, BUN > 19 mg/dL = 1, Age > 65 = 1).
Determines the appropriate site of care (outpatient vs. inpatient ward vs. ICU).
2
Determine the appropriate setting for treatment based on the severity score.
A CURB-65 score of 3 indicates severe community-acquired pneumonia warranting inpatient hospital admission.
Patients with scores 0-1 can typically be treated as outpatients, a score of 2 requires consideration for admission, and 3-5 require hospital admission.
3
Select the guideline-concordant empiric antibiotic regimen for inpatient (non-ICU) community-acquired pneumonia.
The standard of care is an intravenous beta-lactam (e.g., ceftriaxone) plus a macrolide (e.g., azithromycin), or monotherapy with a respiratory fluoroquinolone.
This regimen covers the most common typical and atypical respiratory pathogens without unnecessarily broadening the spectrum.

Key Concept

Empiric antibiotic selection for inpatient community-acquired pneumonia
Question 12Question →

During morning rounds on the medical ward, a consulting physician evaluates a patient admitted overnight for persistent fever, generalized weakness, and dark urine. The patient was seen at an urgent care center one week ago for an erythematous, expanding annular rash with central clearing on the right thigh following a camping trip in Massachusetts. Oral doxycycline was initiated at that time. Although the rash has faded, the patient reports worsening systemic symptoms. Current vital signs include a temperature of 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure of 110/70 mmHg110/70 \text{ mmHg}, and a heart rate of 112/min112/\text{min}. Physical examination is notable for scleral icterus and mild splenomegaly. Laboratory findings show a hemoglobin level of 7.8 g/dL7.8 \text{ g/dL}, platelet count of 95,000/mm395,000/\text{mm}^3, elevated indirect bilirubin, and significantly elevated lactate dehydrogenase. A peripheral blood smear reveals pleomorphic intraerythrocytic organisms, with occasional tetrad formations. Which of the following is the most appropriate modification to this patient's antimicrobial regimen?

Show answer & explanation

Answer: Add atovaquone and azithromycin

Answer

The most appropriate modification is to add atovaquone and azithromycin to the patient's current regimen.
The clinical scenario describes a patient initially treated for early localized Lyme disease who subsequently develops signs of hemolytic anemia (jaundice, dark urine, anemia, elevated LDH and indirect bilirubin) and thrombocytopenia. The Ixodes scapularis tick, which transmits Borrelia burgdorferi, also serves as the vector for Babesia microti and Anaplasma phagocytophilum, making coinfections common in endemic areas like the Northeastern United States. The peripheral blood smear definitively diagnoses babesiosis by demonstrating pleomorphic intraerythrocytic organisms that occasionally form tetrads (the pathognomonic 'Maltese cross' appearance). The most appropriate management is to continue the current course of doxycycline to treat the Lyme disease and concurrently add atovaquone and azithromycin, which is the first-line therapy for mild-to-moderate babesiosis.

Step-by-Step Solution

1
Analyze the patient's initial presentation and geographic risk.
The patient had an expanding annular rash (erythema migrans) after camping in Massachusetts, a highly endemic area for Ixodes scapularis ticks, establishing a diagnosis of early localized Lyme disease (Borrelia burgdorferi).
Establishing the initial diagnosis explains the rationale for the patient's current doxycycline prescription.
2
Evaluate the new-onset symptoms and laboratory findings.
The patient developed dark urine, jaundice, severe anemia (7.8 g/dL7.8 \text{ g/dL}), elevated indirect bilirubin, and elevated lactate dehydrogenase, indicating intravascular hemolysis.
Identifying the pathophysiologic mechanism (hemolysis) narrows the differential diagnosis of tick-borne illnesses.
3
Interpret the peripheral blood smear in the context of the clinical picture.
The smear shows intraerythrocytic organisms with tetrad formations (Maltese crosses). Combined with the hemolytic anemia and the Ixodes tick exposure, this confirms a coinfection with Babesia microti.
Definitive pathogen identification is required to select the targeted antimicrobial therapy.
4
Select the optimal pharmacotherapy.
The standard treatment for mild-to-moderate babesiosis is a combination of atovaquone and azithromycin. Doxycycline should be continued to complete the course for Lyme disease.
Targeted antimicrobial therapy must cover both established pathogens without unnecessarily escalating to broad-spectrum agents.

Key Concept

Patients residing in or traveling to endemic regions (e.g., Northeastern United States) can acquire coinfections transmitted by the Ixodes scapularis tick. The presence of hemolytic anemia and intraerythrocytic tetrads in a patient being treated for Lyme disease indicates a Babesia microti coinfection, requiring the addition of atovaquone and azithromycin.
Question 13Question →

A 35-year-old man comes to the clinic for a routine 6-month sexually transmitted infection screening. He is currently asymptomatic and has no somatic complaints. He reports having multiple male sexual partners. He has no known drug allergies and takes a daily tenofovir-emtricitabine regimen for HIV pre-exposure prophylaxis.

His medical history is significant for a diagnosis of primary syphilis 22 years ago, which was appropriately treated with a single intramuscular injection of benzathine penicillin G. At the time of that diagnosis, his Rapid Plasma Reagin (RPR) titer was 1:641:64. Six months after his treatment, the titer had decreased to 1:21:2.

Review of his medical records shows that during his last routine screening 66 months ago, his RPR titer remained stable at 1:21:2.

Today, his physical examination is unremarkable, with no evidence of chancre, mucosal lesions, maculopapular rash, or neurological abnormalities.

Laboratory results from today's visit:
HIV antigen/antibody test: Negative
RPR: Positive, titer 1:321:32
*Treponema pallidum* particle agglutination (TP-PA): Positive

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer a single dose of intramuscular benzathine penicillin G

Answer

The most appropriate management is to administer a single dose of intramuscular benzathine penicillin G.
The patient presents with an asymptomatic *Treponema pallidum* infection. His RPR has increased from a baseline of 1:21:2 (documented 66 months ago) to 1:321:32. A ≥4\ge 4-fold increase in a non-treponemal titer (e.g., 1:21:2 to 1:81:8, or in this case, a 1616-fold increase to 1:321:32) indicates a reinfection. Because he had a documented titer of 1:21:2 just 66 months ago, the duration of this new infection is definitively known to be less than one year. Therefore, he has early latent syphilis. The standard treatment for early latent syphilis (as well as primary and secondary syphilis) is a single dose of intramuscular benzathine penicillin G.

Step-by-Step Solution

1
Evaluate the current non-treponemal (RPR) titer against the historical baseline.
The RPR titer increased from 1:21:2 (six months ago) to 1:321:32 (today), which is a 1616-fold increase.
A ≥4\ge 4-fold increase in RPR indicates a new, active syphilis infection (reinfection) rather than a historical serofast state.
2
Determine the clinical stage of the syphilis reinfection.
The patient is asymptomatic, meaning the infection is in a latent stage. Because he had a stable low titer just 66 months ago, the new infection was acquired within the past year.
Latent syphilis acquired within the preceding 1212 months is classified as early latent syphilis.
3
Select the appropriate pharmacotherapy for early latent syphilis.
The standard of care is a single dose of intramuscular benzathine penicillin G.
Unlike late latent syphilis (which requires 33 weekly doses), early latent syphilis is effectively treated with a single intramuscular injection.

Key Concept

Early latent syphilis (an asymptomatic infection acquired within the past year, proven by a ≥4\ge 4-fold RPR rise within 1212 months) is treated with a single dose of intramuscular benzathine penicillin G.
Question 14Question →

Match each patient's clinical presentation with the most appropriate antimicrobial stewardship-guided management step.

Click a left item, then click its matching right item

Items

A 3030-year-old man with 44 days of nasal congestion, clear rhinorrhea, and facial pressure. He is afebrile.
A 6565-year-old woman admitted with a severe COPD exacerbation characterized by increased dyspnea, increased sputum volume, and increased sputum purulence.
A 2222-year-old woman with a severe sore throat, a temperature of 38.5∘C38.5^\circ\text{C} (101.3∘F101.3^\circ\text{F}), tender cervical lymphadenopathy, and a positive rapid streptococcal antigen test.
A 7575-year-old man with a chronic venous stasis ulcer on his medial malleolus that is weeping clear fluid but has no surrounding erythema, warmth, or purulence.
A 5555-year-old man hospitalized with acute interstitial pancreatitis who develops a fever of 38.2∘C38.2^\circ\text{C} (100.8∘F100.8^\circ\text{F}) on hospital day 22, with no signs of infected necrosis on imaging.

Matches

Show answer & explanation

Answer

Viral rhinosinusitis matches with supportive care. COPD exacerbation matches with a short course of azithromycin/doxycycline. Streptococcal pharyngitis matches with a 10-day course of penicillin/amoxicillin. The uninfected venous ulcer matches with standard wound care without antibiotics. Sterile acute pancreatitis matches with maintaining intravenous fluids and withholding prophylactic antibiotics.
Each correct pairing reflects the principles of antimicrobial stewardship by ensuring antibiotics are prescribed only when clearly indicated (e.g., COPD exacerbation with cardinal symptoms, confirmed streptococcal pharyngitis) and avoided when not indicated (e.g., viral sinusitis, colonized wound, sterile pancreatitis).

Step-by-Step Solution

1
Evaluate the indication for antibiotics in the patient with acute rhinosinusitis.
The duration of symptoms is only 44 days, indicating a viral etiology.
Antimicrobial stewardship dictates avoiding antibiotics for self-limiting viral illnesses unless symptoms persist for more than 1010 days.
2
Assess the criteria for antimicrobial therapy in the patient with a COPD exacerbation.
The presence of all three cardinal symptoms warrants targeted antibiotic use.
Bacterial triggers are common in severe COPD exacerbations, and antibiotics improve outcomes in this specific subgroup.
3
Determine the management for confirmed streptococcal pharyngitis.
Antibiotic treatment with penicillin or amoxicillin is required.
Treatment eradicates the pathogen, shortens symptom duration, and significantly reduces the risk of acute rheumatic fever.
4
Analyze the need for antibiotics in the patient with a chronic venous ulcer.
Systemic antibiotics are unnecessary.
The ulcer shows no signs of acute infection (erythema, warmth, purulence). Treating colonization promotes antibiotic resistance without providing clinical benefit.
5
Review the role of prophylactic antibiotics in the patient with acute pancreatitis.
Prophylactic antibiotics are contraindicated.
Early fever in pancreatitis is usually due to the systemic inflammatory response syndrome (SIRS), not a bacterial infection.

Key Concept

Antimicrobial Stewardship in Internal Medicine
Question 15Question →

A 42-year-old man presents to the emergency department with a 4-week history of productive cough, low-grade fever, drenching night sweats, and a 5-kg (11-lb) weight loss. He emigrated from a country with a high incidence of tuberculosis two years ago. Vital signs show a temperature of 38.1°C (100.6°F), heart rate of 92/min, blood pressure of 120/78 mm Hg, respiratory rate of 18/min, and oxygen saturation of 97% on room air. Physical examination reveals bronchial breath sounds and crackles in the right upper lung field. He is currently waiting in the general triage area. Arrange the following management steps in the most appropriate chronological order.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first place the patient in airborne isolation, followed by obtaining a chest radiograph, then collecting sputum for microbiological testing, and finally initiating empiric four-drug antimycobacterial therapy.
In a patient presenting with classic signs of active pulmonary tuberculosis (cough, weight loss, night sweats, endemic country exposure), the immediate priority is public health and infection control. The patient must be immediately moved from the general triage area to a negative-pressure airborne infection isolation room. Once isolated, a chest radiograph is obtained to evaluate for characteristic pulmonary lesions. Following imaging, three consecutive sputum specimens are collected for acid-fast bacilli (AFB) smear, culture, and nucleic acid amplification testing. Crucially, sputum collection must occur before antimycobacterial agents are given to ensure the highest yield for cultures and susceptibility testing. Finally, empiric four-drug therapy (rifampin, isoniazid, pyrazinamide, ethambutol) is initiated while awaiting the microbiological results.

Step-by-Step Solution

1
Place the patient in an airborne infection isolation room.
The patient is moved to a negative-pressure room.
The patient's clinical presentation is highly suspicious for active pulmonary tuberculosis. Immediate airborne isolation prevents transmission to healthcare workers and other vulnerable patients in the triage area.
2
Obtain a posterior-anterior and lateral chest radiograph.
Radiographic evidence of the disease is visualized.
A chest radiograph is a rapid, non-invasive diagnostic test that helps confirm the suspicion of pulmonary tuberculosis (e.g., showing upper lobe infiltrates or cavitary lesions) before proceeding to more resource-intensive testing.
3
Collect three consecutive sputum specimens for acid-fast bacilli smear, NAAT, and culture.
Pathogen samples are secured for identification and susceptibility testing.
Sputum must be collected before the administration of antibiotics to prevent sterilizing the sample, which would hinder pathogen isolation and crucial drug susceptibility profiling.
4
Initiate empiric therapy with rifampin, isoniazid, pyrazinamide, and ethambutol.
The patient begins active treatment for mycobacterial infection.
Once isolation is established and diagnostic cultures are safely collected, empiric RIPE therapy is initiated to treat the likely active tuberculosis infection while awaiting culture results.

Key Concept

The sequential management of suspected active pulmonary tuberculosis prioritizes infection control (airborne isolation) first, followed by diagnostic imaging, microbiological sampling, and finally the initiation of empiric medical therapy.
Question 16Question →

Match each clinical presentation of genital ulcer disease to the most appropriate first-line pharmacotherapy.

Click a left item, then click its matching right item

Items

A 25-year-old man with a single, painless, indurated penile ulcer with a clean base and bilateral non-tender inguinal lymphadenopathy.
A 22-year-old woman with multiple extremely painful vulvar vesicles on an erythematous base that have ulcerated, accompanied by dysuria and tender inguinal lymphadenopathy.
A 28-year-old man with a deep, exquisitely painful penile ulcer with ragged, undermined edges and a purulent base, accompanied by a unilateral, tender, fluctuant inguinal lymph node.
A 32-year-old man with a unilateral, painful, fluctuant inguinal mass (bubo) who recalls a small, transient, painless genital ulcer that resolved spontaneously 3 weeks ago.

Matches

Show answer & explanation

Answer

The correct matches pair Primary Syphilis with Benzathine penicillin G, Genital Herpes with oral antivirals, Chancroid with Azithromycin or Ceftriaxone, and Lymphogranuloma Venereum with a 21-day course of Doxycycline.
Each classic genital ulcer presentation corresponds to a specific organism and a guideline-directed treatment regimen. A painless, indurated ulcer with non-tender nodes is typical for primary syphilis (Treponema pallidum), requiring intramuscular benzathine penicillin G. Painful vesicles or shallow ulcers point to genital herpes (HSV), treated with oral antivirals. Deep, painful ulcers with a purulent base and tender nodes suggest chancroid (Haemophilus ducreyi), treated with azithromycin or ceftriaxone. A painless transient ulcer followed by painful inguinal buboes indicates lymphogranuloma venereum (Chlamydia trachomatis L1-L3), which necessitates a 21-day course of oral doxycycline.

Step-by-Step Solution

1
Evaluate the clinical characteristics of the genital ulcer (painful vs. painless).
Painful ulcers suggest genital herpes (HSV) or chancroid. Painless ulcers suggest primary syphilis, lymphogranuloma venereum (LGV), or granuloma inguinale.
Pain is the most important initial differentiating factor in the clinical diagnosis of genital ulcer disease.
2
Assess the characteristics of the associated regional lymphadenopathy.
Non-tender lymphadenopathy points to syphilis. Tender lymphadenopathy points to HSV or chancroid. Painful, fluctuant buboes appearing weeks after a transient initial ulcer point to LGV.
Lymph node involvement patterns are highly specific to the causative pathogen and help confirm the diagnosis.
3
Match the identified clinical syndrome with the current guideline-directed first-line antimicrobial therapy.
Syphilis requires benzathine penicillin G, HSV requires antivirals, chancroid requires azithromycin or ceftriaxone, and LGV requires a 21-day course of doxycycline.
Empiric treatment must rapidly and specifically target the most likely organism to prevent disease transmission and complications.

Key Concept

Identifying the etiology of genital ulcer diseases based on clinical features (painful vs. painless, presence and type of lymphadenopathy) is essential for selecting the correct first-line empiric antimicrobial therapy.
Question 17Question →

An 82-year-old woman residing in a skilled nursing facility is evaluated during a routine monthly check-up. Her medical history includes Alzheimer dementia, hypertension, and type 2 diabetes mellitus. The facility staff requested a urinalysis today because they noted her urine has appeared cloudy and malodorous over the past three days. The patient has no complaints and denies any pain. Temperature is 37.0°C (98.6°F), blood pressure is 138/82 mm Hg, pulse is 76/min, and respirations are 14/min. The patient is alert, pleasant, and oriented to her own name, which is consistent with her baseline mental status. Abdominal examination reveals a soft, non-distended abdomen with no suprapubic or costovertebral angle tenderness. A clean-catch urinalysis shows a specific gravity of 1.015, pH 6.5, positive leukocyte esterase, positive nitrites, and 45 white blood cells/hpf. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Observation without further intervention

Answer

Observation without further intervention
The correct management is observation without further intervention because the patient meets the criteria for asymptomatic bacteriuria (ASB). She has laboratory evidence of urinary bacteria and inflammation (pyuria, nitrites) but absolutely no systemic signs of infection (she is afebrile and hemodynamically stable) or localized urinary symptoms (no dysuria, suprapubic pain, or acute alteration in mental status from baseline). In older adults residing in long-term care facilities, ASB is exceedingly common. Clinical guidelines strongly recommend against screening for or treating ASB in this population, as antimicrobial therapy has not been shown to reduce morbidity or mortality, but significantly increases the risk of adverse drug events and the development of multidrug-resistant organisms.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and vital signs.
The patient is afebrile, hemodynamically stable, and at her cognitive baseline, with no localized urinary symptoms or suprapubic/CVA tenderness.
To distinguish between a symptomatic urinary tract infection (UTI) and asymptomatic bacteriuria (ASB).
2
Evaluate the laboratory findings in the context of the clinical picture.
Urinalysis shows pyuria (leukocyte esterase, 45 WBCs/hpf) and bacteriuria (nitrites), but the patient has cloudy/malodorous urine as the only reported change.
Cloudy or foul-smelling urine frequently prompts unnecessary testing in long-term care facilities, but these characteristics alone do not define a symptomatic UTI.
3
Determine the appropriate management for ASB in an older, institutionalized patient.
Guidelines dictate that ASB should not be screened for or treated with antibiotics, except in specific populations (e.g., pregnant women, patients undergoing urologic procedures).
Treatment does not reduce the frequency of symptomatic UTIs or improve survival, but it does increase the risk of adverse drug events and resistant organisms.

Key Concept

Asymptomatic bacteriuria is common in elderly institutionalized patients and should not be treated with antibiotics or further evaluated with urine cultures unless specific systemic or localized urinary symptoms are present.
Estimated Time:1m 0s
Question 18Question →

A 52-year-old man is brought to the emergency department by his wife due to a 24-hour history of high fever, severe generalized headache, and progressive confusion. On physical examination, his temperature is 39.2°C (102.6°F), blood pressure is 110/70 mmHg, heart rate is 115/min, and respiratory rate is 18/min. He is lethargic but arousable. Neurologic examination reveals marked nuchal rigidity and a new, mild right-sided hemiparesis. Fundoscopic examination shows early papilledema. The physician suspects acute bacterial meningitis. Arrange the following steps in the most appropriate chronological order for the initial management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Obtain blood cultures, 2) Administer empiric intravenous antibiotics and dexamethasone, 3) Perform a non-contrast CT scan of the head, 4) Perform a lumbar puncture.
The correct sequence prioritizes rapid initiation of antimicrobial therapy while safely managing the risk of brain herniation. First, blood cultures must be obtained to maximize the chances of identifying the causative pathogen. Second, because this patient has indications for neuroimaging prior to a lumbar puncture (papilledema, right-sided hemiparesis, and altered mental status), empiric intravenous antibiotics and dexamethasone must be administered immediately. Delaying therapy for imaging increases mortality. Third, a non-contrast head CT is performed to safely rule out mass effect. Finally, once the CT scan confirms it is safe, a lumbar puncture is performed to obtain cerebrospinal fluid for definitive diagnosis.

Step-by-Step Solution

1
Identify indications for neuroimaging prior to lumbar puncture.
The patient has papilledema, altered mental status, and a focal neurologic deficit (hemiparesis), which strongly indicate the need for a head CT before a lumbar puncture.
Performing a lumbar puncture in the presence of elevated intracranial pressure from a mass lesion can precipitate fatal brain herniation.
2
Determine the correct timing for blood cultures and antimicrobial therapy.
Blood cultures are prioritized as the immediate first step, followed directly by the administration of empiric antibiotics and dexamethasone.
Antibiotics should never be delayed while waiting for a CT scan, but blood cultures must be drawn just prior to antibiotics to ensure accurate pathogen identification.
3
Sequence the diagnostic procedures.
The CT scan is performed after therapy has been successfully initiated, followed finally by the lumbar puncture.
This sequence ensures life-saving treatment is given rapidly while still allowing for a safe and definitive diagnostic evaluation of the cerebrospinal fluid.

Key Concept

In patients with suspected bacterial meningitis and indications for a CT scan before lumbar puncture (e.g., focal neurologic deficit, papilledema, altered mental status), blood cultures should be drawn first, followed immediately by empiric antibiotics and dexamethasone, before proceeding with neuroimaging and the lumbar puncture.
Question 19Question →

A 6868-year-old man is evaluated in the intensive care unit for a new-onset fever and increased respiratory secretions. He has been receiving mechanical ventilation for 77 days following a severe cerebrovascular accident. His temperature is 38.8∘C38.8^\circ\text{C} (101.8∘F101.8^\circ\text{F}), blood pressure is 110/70 mmHg110/70\text{ mmHg}, and pulse is 105/min105/\text{min}. Physical examination reveals coarse crackles in the right lower lung field. A chest radiograph demonstrates a new right lower lobe infiltrate. Endotracheal aspiration is performed, and empiric intravenous therapy with cefepime, tobramycin, and vancomycin is initiated.

Forty-eight hours later, the patient's temperature is 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}) and his oxygenation has steadily improved. The endotracheal aspirate culture grows 106 CFU/mL10^6\text{ CFU/mL} of *Pseudomonas aeruginosa*. Antimicrobial susceptibility testing indicates the organism is susceptible to cefepime, meropenem, and tobramycin, but resistant to levofloxacin. No other organisms are isolated. Which of the following is the most appropriate next step in the management of this patient's pharmacotherapy?

Show answer & explanation

Answer: Discontinue vancomycin and tobramycin, and continue cefepime

Answer

Discontinue vancomycin and tobramycin, and continue cefepime
The most appropriate next step is to discontinue vancomycin and tobramycin, and continue cefepime as monotherapy. This patient was appropriately started on broad-spectrum empiric therapy for ventilator-associated pneumonia (VAP), which commonly includes coverage for MRSA (vancomycin) and double coverage for *Pseudomonas aeruginosa* (cefepime and tobramycin). However, once culture results are available and the patient demonstrates clinical improvement, antimicrobial stewardship principles dictate rapid de-escalation. Because the endotracheal aspirate culture did not grow MRSA, vancomycin should be stopped. Furthermore, routine definitive double-coverage for *Pseudomonas* is not recommended. Once the isolate is confirmed to be susceptible to an active beta-lactam (cefepime), the second antipseudomonal agent (tobramycin) should be discontinued to minimize unnecessary nephrotoxicity and ototoxicity.

Step-by-Step Solution

1
Evaluate the patient's clinical response to the empiric antimicrobial therapy.
The patient's fever has resolved (37.2∘C37.2^\circ\text{C}) and his oxygenation has improved, indicating clinical stability and a positive response to the current regimen.
Clinical stability dictates whether de-escalation is safe; deteriorating patients may require broader or alternative coverage.
2
Analyze the microbiological culture and susceptibility results.
The culture isolated only *Pseudomonas aeruginosa*, which is susceptible to cefepime. No Methicillin-resistant *Staphylococcus aureus* (MRSA) was grown.
Definitive culture data allows the medical team to target the specific pathogen and safely remove unnecessary broad-spectrum agents.
3
Modify the antimicrobial regimen based on standard stewardship guidelines for ventilator-associated pneumonia (VAP).
Vancomycin is discontinued due to the absence of MRSA, and tobramycin is discontinued because dual coverage for *Pseudomonas* is no longer indicated. Cefepime is continued as targeted monotherapy.
Once susceptibility to an active beta-lactam is confirmed in a responding patient, continuing a second antipseudomonal agent (like an aminoglycoside) only adds toxicity without improving clinical outcomes.

Key Concept

Antimicrobial de-escalation in ventilator-associated pneumonia (VAP) involves transitioning from broad-spectrum empiric therapy (MRSA coverage + double antipseudomonal coverage) to targeted monotherapy based on culture susceptibilities and clinical improvement.
Estimated Time:1m 30s
Question 20Question →

A 68-year-old male is currently receiving care in the intensive care unit for acute respiratory distress syndrome secondary to severe acute pancreatitis. He has been mechanically ventilated for the past 11 days. Over the last 48 hours, his oxygen requirements have increased, and he has developed copious purulent endotracheal secretions. His temperature is 38.8°C (101.8°F), blood pressure is 110/65 mm Hg, and pulse is 112/min. Physical examination reveals coarse crackles in the right lung base. A portable chest radiograph demonstrates a new right lower lobe consolidation. Endotracheal aspirate and blood cultures are obtained, and the patient is empirically started on intravenous vancomycin, meropenem, and tobramycin.

Two days later, the patient's clinical status has improved, and he is afebrile. Blood cultures show no growth. The endotracheal aspirate culture yields heavy growth of *Enterobacter cloacae*. The antimicrobial susceptibility report is as follows:

AntimicrobialInterpretation
AmpicillinResistant
CefazolinResistant
CefepimeSusceptible
CeftriaxoneSusceptible
MeropenemSusceptible
Piperacillin-tazobactamSusceptible
TobramycinSusceptible

Which of the following is the most appropriate next step in the pharmacologic management of this patient's infection?

Show answer & explanation

Answer: Discontinue vancomycin and tobramycin; switch meropenem to cefepime

Answer

Discontinue vancomycin and tobramycin; switch meropenem to cefepime
The correct approach is to discontinue vancomycin and tobramycin and switch meropenem to cefepime. The patient has ventilator-associated pneumonia caused by Enterobacter cloacae. Once culture and susceptibility data are available, empiric broad-spectrum therapy should be tailored to the narrowest effective agent. Enterobacter cloacae, Klebsiella aerogenes, and Citrobacter freundii are organisms with a moderate-to-high risk of inducible AmpC beta-lactamase production. When these organisms are exposed to third-generation cephalosporins (like ceftriaxone), derepressed mutants that hyperproduce AmpC are selected, leading to clinical failure despite reported in vitro susceptibility. Therefore, ceftriaxone must be avoided. Cefepime, a fourth-generation cephalosporin, forms a stable zwitterion that quickly penetrates the outer membrane and is a weak inducer of AmpC, making it stable against hydrolysis. It is the preferred agent when the minimum inhibitory concentration suggests susceptibility. Discontinuing vancomycin and tobramycin eliminates unnecessary MRSA and double-pseudomonal coverage, minimizing nephrotoxicity.

Step-by-Step Solution

1
Diagnose the clinical condition based on the vignette.
The patient has developed ventilator-associated pneumonia (VAP).
New fever, purulent secretions, increased oxygen requirements, and a new consolidation on chest radiography after 11 days of mechanical ventilation confirm VAP.
2
Analyze the culture data and pathogen characteristics.
The infection is monomicrobial, caused by Enterobacter cloacae. This organism possesses an inducible chromosomal ampC gene.
Enterobacter cloacae is one of the classic 'SPACE' or 'HECK-Yes' organisms that are at high risk for producing clinically significant AmpC beta-lactamases.
3
Select the optimal definitive antimicrobial therapy based on stewardship guidelines.
Cefepime is chosen to de-escalate therapy.
Cefepime is stable against AmpC hydrolysis and does not induce derepressed mutants. Ceftriaxone is contraindicated despite in vitro susceptibility. Meropenem is overly broad and should be spared for resistant pathogens.

Key Concept

Definitive antimicrobial selection for moderate-to-high risk AmpC-producing Enterobacterales requires agents stable against AmpC hydrolysis, such as cefepime, while avoiding third-generation cephalosporins despite apparent in vitro susceptibility.
Page 1 / 26Next
Infectious Diseases Practice Questions — USMLE Step 2 CK | Examkin